Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It is intended to support nutritional needs in patients requiring specialized amino‑acid supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino‑acid supplementation and is used in clinical situations where protein metabolism is compromised. - Metabolic disorders: helps maintain nitrogen balance and supports growth in patients with inborn errors of metabolism. - Post‑surgical recovery: contributes to tissue repair and nitrogen retention during convalescence. - Critical illness or trauma: assists in preserving lean body mass and supports immune function in severely ill patients.

Amino‑acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild gastrointestinal discomfort reported in some patients. - Diarrhea: loose stools may appear, especially with rapid dose escalation. - Abdominal cramping: intermittent stomach pain during intake. - Metallic taste: transient alteration in taste perception. - Headache: mild headache reported occasionally. - Skin redness at site of reconstitution (if applicable).

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis in hypersensitive individuals. - Hyperammonemia: elevated ammonia levels in patients with severe liver dysfunction. - Metabolic acidosis: rare disturbance of acid‑base balance. - Severe electrolyte imbalance: uncommon but possible with high‑dose regimens. - Renal impairment exacerbation: caution in patients with existing kidney disease. - Unexplained fever: may indicate an underlying infection or reaction.

Before initiating therapy with Olimel N9, consider the following precautions: - Renal function: assess kidney performance, adjust dosage if impairment is present. - Hepatic function: monitor liver enzymes, especially in patients with liver disease. - Metabolic disorders: evaluate baseline amino‑acid levels to avoid excess. - Pregnancy and lactation: use only if clearly needed, after risk‑benefit assessment. - Concomitant nutrition therapy: coordinate with dietitian to prevent over‑supplementation. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid preparations can interact with certain medications and nutrients.

Major Interactions (Avoid): - Levodopa: may reduce absorption of levodopa, diminishing its efficacy in Parkinson's disease. - Anticonvulsants (e.g., phenobarbital): can increase catabolism of amino acids, lowering therapeutic benefit. - Iron supplements: concurrent intake may impair iron absorption.

Moderate Interactions (Monitor Closely): - Thyroid hormones: high amino‑acid load may affect thyroid hormone binding. - Diuretics: risk of electrolyte shifts when combined with high‑dose amino‑acid solutions. - Antibiotics (e.g., tetracycline): may chelate with amino acids, reducing antibiotic absorption.